Physiological & Biochemical Process regulating Parturition. Physiological process in human pregnancy that result in initiation of parturition & onset of labor : poorly defined Retreat from pregnancy maintenance & uterotonin induction of parturition hypotheses
01 / 99Physiological & Biochemical Process regulating Parturition
1 / 17
Télécharger la présentation
Physiological & Biochemical Process regulating Parturition
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation
Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement.Téléchargez la présentation en cliquant sur ce lien.Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.
F I N
Plus de contenu associé
Transcription de la présentation
Physiological & Biochemical Process regulating Parturition • Physiological process in human pregnancy that result in initiation of parturition & onset of labor : poorly defined • Retreat from pregnancy maintenance & uterotonin induction of parturition hypotheses • Mature human fetus : source of initial signal for commencement parturitional process • One or more uterotonins: initiation of human parturition ( myometrial R. elevation)
Anatomical & physiological consideration of myometrium • Characteristics – advantage in efficiency of uterine contractions & delivery of fetus ① degree of shortening of smooth m cells with contraction : magnitude greater than in striated m cells ② forces can be exerted in smooth m cells in any direction ③ not organized in same manner as skeletal m - thick & thin filaments in long, random bundles → greater shortening & force-generating capacity ④ multidirectional force generation
Regulation of myometrial contraction & Relaxation • Interaction of myosin & actin activation of adenosine triphosphatase ATP hydrolysis force generation (by enzymatic phosphorylation of MLC) • Ca bind to calmodulin activate myosin light chain kinase increase in intracellular Ca2+ (transient) • Contraction prolonged inhibition of myosin phosphatase activity by Rho kinase • Uterine activity regulation of contraction –associated protein (CAP) : include channels associaeted with smooth m excitation & contraction , gap junction component, uterotonic stimulatory or inhibitory R
1] Myometrial Gap junctions • Cellular signals transferred between cells through intercellular junctional channels • Communication is extabilished between myometrial cells by gap junctions that facilitate passage of electrical or ionic coupling current as well as metabolite coupling • Consist of two protein ”hemi-channels “ termed connexons hexameric assemblage of type of protein called connexin • Conduit for exchange of small molecule • Gap junctions optimal No : electrical synchrony in myometrium , coordination of contraction ( greater force during labor)
2] Cell surface R as regulator of myometrium • Estrogen & progesteron R, variety of cell surface R that can directly regulate contractile state of cell • Most of heptahelical R in myometrium • Activation of adenylycyclase • G-protein-medicated activation of phospholipase C [Ca2+]) ↑& myometial cell contraction ↑ • In high concentration: from maternal blood (endocrine), contiguous tissues or adjacent cells (paracrine) or direct synthesis in myometrial smooth m cell (autocrine) [Fig 6-16]
2] Cell surface R as regulator of myometrium • Myometrial response to H. can change during course of pregnancy • Imposition of quiescence (activation of adenylyl cyclase) or facilitation of contraction ( activation of phospholipase C & increased [Ca+])
A Fail-Safe system that maintains Ut quiescence • Multiple process act independently & cooperatively to estabilish ut quiescence • To sustain Ut quiescence of phase 0 : biomolecular systems ( neural, endocrine, paracrine, and autocrine )
A Fail-Safe system that maintains Ut quiescence • Phase 0 of parturition & its quiescent state factor • Actions of estrogen & progesterone via intracellular R • Myometrial cell plasma membrane R –mediated increase in cAMP • Generation of cGMP • Other systems, including modifications in myometrial cell ion channels
Progesterone & Estrogen contributions to Phase 0 of parturition • Maintains Phase 0 of human parturition • Removal of Progesterone ( Progesterone withdrawal) : progression of phase 0 into phase 1 of parturition • Progesteron action: • Successful maintenance of preg • Biomolecular evidence or role of other agents not defined • Maintain Phase 0 of human parturition • Estrogen action : • Promote progesteron responsiveness Ut quiescence • In responsive tissues, Estrogen R. induces Progesteron R synthesis
Steroid H Regulation of myometrial Cell-to-Cell communication • Progesteron • Decrease expression of contraction associated proteins • CAP grouping : smooth m excitation contraction, gap junction components uterotonic stimulatory R • Inhibit expression of gap junctional protein connexin 43 • Progesterone antagonist: premature development of gap junction preterm labor & delivery • Connexin 43 mRNA in human myometrial tissue increase before labor between 37 ~40 wks. • Gap junction in myometrium increase • But expression of connexin 43 protein not increase during gestation or at labor ? in intracellular regulator of actual gap junction assembly at time of labor
Heptahelical R that promote myometrial relaxation • Multiple process act independently & cooperatively to estabilish ut quiescence • Associated with Gas-mediated activation of adenyly cyclase & increased level of cAMP in myometrium • Part of fail-safe system to maintain Ut quiescence of phase 0 of parturition
B-adrenoreceptors • B-adrenoreceptors mediate Gas- stimulated increase in adenylyl cyclase increased level of cAMP myometrial cell relaxation • Exact role of catecholamines in maintaining ut quiescence : ill defined
Luteinizing H (LH) & chorionic gonadotropin(hCG) • LH & hCG R in myometrium during preg greater before than during labor • Chorionic gonadotropin(hCG) activate adenylyl cyclase by plasma memb R Gas-linked system • decrease in contraction frequency & force & tissue-specific myometrial cell gap junctions
Relaxin • Peptide H member of insulin like growth factor family of proteins, A & B chain • Secretion from corpus luteum • Greates & peak at 1ng/ml 8wks ~12wks. • Thereafter decline to lower lever until term • Activation of adenylyl cyclase & promotes myometrial realxation, effect cervical softening
Corticotropin–Releasing H(CRH) • Myltiple isoforms their affinity & coupling modified late in preg • Sythesized in PL,amnion,decidua,myometrium • Increase final 6~8wks of preg • Signal through cAMP or Calcium • Relaxation or contraction of myometrial cell depending on R isoform present • CRH role of uterorelaxant during phase 0 & uterotonin in phases 1 & 2 of parturition
Parathyroid H–related protein (PTH-rP) • Initiate Gas-medated activation of adenylyl cyclase • Expressd in myometrium,amnion,decidua & trophoblast • PTH-rP expression in smooth m icreased by m stretch • Function : not established,serve to maximize ut blood flow durng myometrial contraction by vasorelaxant action • Facilitate maintenance of Ut tranquility
Prostaglandins • Interact with family of 8 different heptahelical R • PG : uterotonins,prostanoid sometimes can act as smooth m relaxant • Individual prostanoid : diverse effect
Prostaglandins • By action of phospholipase A2 or C • Arachidonic acid act as substrate of type 1 & type 2 PG synthase (PGHS-1 & -2) called COX –1 & –2 • Both convert Arachidonic acid to unstable endoperoxide PG G2 and then to PGH2target of many NSAIDs & act as tocolytics to prevent preterm labor • PGH2 convert to active PG (PGE2,PGF2 & PGI2) • PGDH Expression :regulate in Ut rapidly incactivate PG metabolites
Prostaglandins • PG family of R classifed according to specificity of binding of given R to particular PG • DP(PGD2) & IP (prostacyclin or PGI2) : increase intracellular cAMP • FP R (PGF2a) : increase intracellular Ca • EP2 & EP4 (PGE2): activate cAMP production • PGE2 PGI2 : maintain Ut quiescence by increasing cAMP signaling • PGE2,PGD2,PGI2 : relaxation of vascular smooth m & vasodilation
Prostaglandins • Either generation of specific PG or relative expression of various PG R determine responses of human myometrium • Change with gestation (32~35 wks vs 39~40wks .) • Regional change in upper & lower ut segment • Prostanoid : myometrial relaxation at one stage of preg & regional myometrial contraction after initiation of parturition (in fundus)
Atrial & Brain natriuretic peptides & cyclic guanosine monophosphate(cGMP) • Guanylyl cyclase activation increase intracellular level of cGMP promote smooth m relaxation • ANP & BNP stimulate intracellular level of cGMP↑ • BNP secreated by amnion,ANP expressed in PL • Soluble form Guanylyl cyclase activated by nitric oxide penetrate pl membrane to enter cell • NO react with iron in Guanylyl cyclase enzyme stimulate to produce cGMP act myometrial relaxation
Accelerated Uterotonin degradation & Phase 0 of parturition • To stimulate myometrial cell refractoriness, Activity of enzyme↑: degrade or inactivate endogenoulsy produced uterotonins • Uterotonins (degredative enz) PG(PGDH), endothelin (enkephalinase), oxytocin (oxytocinase), histamine (diamine oxidase), catecholamines(catechol O-methlytransferase), angiotensin-II (angiotensinase), PAF(PAF –acetylhydrolase) • These enzyme increase by Progesteron action & decrease late in gestation
Fail-safe system for Ut activation • Phase 1 of parturition: morphological & functional change in myometrium & Cx that prepare Ut for labor • Development of uterotonin sensitivity, improved intercellular communicability via gap junctions • Alteration incapacity of myometrial cell to regulate concentration of cytoplasmic Ca2+ • The process leading to enhance uterine responsiveness activation (by Chalis & associates (2000)) • As fuctional contractile capacity of myometrium & Cx ripened, phase1 merge into phase 2 • Alteration in timing of these process cause preterm & delayed labor
Classical Progesteron withdrawal not cause human parturition • In many species, plasma progesterone level decrease • Activation of Ut in preparation for labor • Associated with increase in estrogen level in several species • In primate, plasma progesteron level not decrease before labor, only after delivery of PL decline • Nonetheless, morphological & fuctional modification that prepare Ut for labor occur in timely manner in human
Classical Progesteron withdrawal not cause human parturition • In species, Progesteron withdrawal can be blocked by administering Progesteron to mother • Conflicting reports whether or not Progesteron delay timely onset of parturition or prevent preterm labor • Majority of studies Progesteron cannot prevent preterm labor not appear to extend labor in control group • Progesteron metabolite, 17-hydroxy progesteron (less potent than Progesteron ):minimally decreased incidence of preterm labor in high –risk group • additional research need
Progesteron R Antagonist & human parturition • RU 486, mifepristone: less effective in inducing abortion or labor in later preg , effective in ripening Cx & increase myometrium sensitivity to uterotonins (Chwalisz & Garfield,1994) • Decreased circulating progesterone by inhibitioning enzyme 3B-hydroxysteroid degydrogenase induced labor • Inhibition of progesterone action: important for activation phase of parturition • But there is : ‘hidden’ or unique form of fuctional progesteron withdrawal that end ut quiescence
Fuctional Progesteron withdrawal in human parturition • Unique mechanisms to inhibit progesterone action in human • Late gestational decrease in activity of progesteron R expression that cause fuctional withdrawal • Changes in relative expression of progesterone R or of its two isoforms • shift in relative ratio of PR-A to PR-B(active isoform) within myometrium • Activity of Progesteron R for gene transcription in late gestation • coactivator ↓ • co-repressor ↑
Oxytocin R • Oxytocin R : increase in myometrium during phase 1 of parturition • Progesterone & estradiol :primary regulator of Oxytocin R expression • Estradiol increase in myometrial Oxytocin R • Progesterone increase in myometrial Oxytocin R degradation inhibit oxytocin R activation at cell surface maintain Ut quiescence through inhibition of myometrial oxytocin response
Fetal contributions to initiation of parturition • After growth & maturation of vital organs, fetus provide initial signal that set parturitional process • Via fetal brain, pituitary gl. adrenal gl. Fetal blood to placenta • Unlikely initial signal for phase 1 of parturition is uterotonin • But Ut first must be prepared for labor before uterotonin optimally effective
Role of Ut strecth in parturition • In association with fetal growth, significant increase in myometrial tensile stress & amnionic fluid pressure • Studies in rat models, strecth was required for normal induction of specific contraction-associated pretein(CAPs) • Stretch expression of gap junction protein↑,connexin 43 & oxytocin R • Twin preg & hydramnios(Uterine stretch occur): at much greater risk of preterm labor
Role of Ut strecth in parturition • Cell signaling systems used by stretch to regulate myometrial cell: mechanotransduction • Activation of cell surface R or ion channels • signaling through extracellular matrix • through release of autocrine molecule that act directly on myometrial cell
Fetal endocrine Cascades Leading to parturition • Placental-Pituitary –adrenal axis role in timing of human parturition • Activation of human fetal hypothalamic-Pituitary –adrenal axis :critical component of normal parturition • Steroid product of fetal adrenal gl : effect on placenta & memb : promote myometrium quiescent ---> contractile state • Key component: CRH (corticotropin-releasing H)
Action of CRH on fetal adrenal Gland • Weigh same & similar size in adult • Daily production of steroid 100~200 mg/day • Steroidogenic fuction different from adult • Fetal cortisol level increase during last wks of gestation • Increased DHEA-S production increase in maternal estrogens (estriol) • Increase in adrenal activity in contrast fetal adrenocorticotropic H (ACTH) do not increase until stress of actual labor • ACTH levels do not increase during last gestation • Growth and differentiation of fetal adrenal gland influenced by factors secreted by placenta • Fetal zone of adrenal gland : rapid involution immediately after birth when placenta derived factors no longer available
Action of CRH on fetal adrenal Gland • CRH of placental origin : one of critical component that facilitate fetal adrenal hypertrophy & increase steroidogenesis late in gestation. • Ability of CRH to regulate adrenal gland & of adrenal to regulate placental production of CRH feed-forward endocrine cascade late in gestation
Placental CRH production • Unlike hypothalamic CRH, cortisol stimulate placental CRH feed-forward endocrine cascade until separation of fetus from placenta at delivery • Rise in CRH as well as fetal adrenal steroidogenesis in late gestation • Maternal plasma CRH low in first trimester, rising from midgestation to term • In last 12 wks, CRH level rise exponentially, peaking during labor then falling after delivery • Amnionic fluid levels of CRH increase in late gestation
Placental CRH production • Late pregnancy: CRH-BP level in both maternal plasma & Amnionic fluid decline • CRH level increasing • bioavailable CRH level increasing • Various Complications, CRH concentration in fetal plasma & amnionic fluid,maternal plasma increasing over normal gestation • PL source for stress-associated increase in CRH fetal adrenal cortisol synthesis • Supranormal level of umbilical cord blood cortisol: occurred in stressed neonates
Potential Roles of CRH in timing of parturition • Roles of PL CRH in regulation of parturition 1.Enhance fetal cortisol production((+) feedback on PL produce more CRH) • Modulate myometrial contractility 2.Cortisol affect myometrium indirectly by stimulating membranes to increase PG synthesis 3.CRH stimulate featal adrenal C19-steroid synthesis, increased substrate for PL aromatization • Elevation in estrogens shift estrogen-to-progesterone ratio promote expression of contractile protein in myometrium
Fetal anomalies & delayed parturtion • Hypoestrogenism : prolonged gestation • Fetal anencephaly, adrenal hypoplasia, placental sulfatase deficiency • Fetal anencephaly : prolong human gestation (anomalous brain-pituitary-adrenal fuction) • Fetal adrenal gland hypoplasia :onset of labor delayed • Fetal adrenal gland important for timely onset of parturtion
Fail-safe system for Success of phase 2 of Parturition • Phase 2 of Parturition :Ut contraction that bring progressive cervical dilatation & delivery • Formation of uterotonins most likely cause of initiation of labor • Oxytocin,PG,serotonin,histamine,PAF, angiotensin II • Activate Gzi or Gaq-mediated processes increase myometrial cell [Ca2+] • Stimulate smooth m contraction through such G-protein coupling
Oxytocin & Phase 2 of Parturition • During phase 1 of Parturition :50-fold or more increase in No of myometrial Oxytocin R • Uterine contractile responsiveness to Oxytocin increase • Nanopeptide synthesized in magnocellular neurons of supraoptic & paraventricular neurons • Oxytocin proH transport Carrier protein (neurophysin), along axons to neural lobe of post pituitary gl in membrane bound vesicles for storage and later release • Oxytocin proH converted enzymatically to oxytocin during transport • Oxytocin not cause initiation of parturition but one of several participants in effectiveness of active labor • Oxytocin act by way of heptahelical R, activate phospholipase
Role of Oxytocin in Phase 2 & Phase 3 of Parturition • Striking increase in No of Oxytocin R in myometrial & decidual tissues near end of gestation • Oxytocin act on decidual tissue to promote PG release • Oxytocin synthesized directly in decidual & extraembryonic fetal tissues & in placenta • Evidence in support of important role for Oxytocin during 2nd stage labor & puerperium • Oxytocin level increase • (1) during 2nd stage labor (end of phase 2 of parturition) • (2) In early postpartum period • (3) Breast feeding (phase 3 of parturition)
Role of Oxytocin in Phase 2 & Phase 3 of Parturition • This timming of increased Oxytocin release : role for Oxytocin at end of labor & during puerperium • After completion of Ut phase 2,persistent contraction =>prevent postpartum hemorrhage • Oxytocin infusion in women promote increased level of mRNA in myometrium of genes that encode proteins essential for Ut involution • Oxytocin action at end of labor & during phase 3 of parturition : Ut involution
Connexion au compte
Connectez-vous pour publier votre contenu sur SlideServe.